An article highlighting the second-largest study ever into lacunar strokes, LACI-2, led by Professor Joanna Wardlaw, was featured in the Scotsman. Image Professor Joanna Wardlaw The LACunar Intervention Trial-2 (LACI-2) study was recently featured in The Scotsman & the British Heart Foundation website. The Scotsman, "Edinburgh University study re-launched into stroke treatment to prevent dementia" The British Heart Foundation, "Trial resumes to prevent dementia after a stroke" The LACI-2 study aims to assess safety & efficacy of inexpensive & widely accessible medication - cilostazol & isosorbide mononitrate to prevent recurrent lacunar stroke & progression of cerebral small vessel disease. The research suggests that lacunar lesions could also be the underlying cause of nearly half of all dementias. The study resumed recruiting participants after the break caused by the COVID-19 pandemic. The study is funded by the British Heart Foundation & led by Professor Joanna Wardlaw, Chair of Applied Neuroimaging & Head of Neuroimaging Sciences & Edinburgh Imaging. If you would like to participate in the LACI-2 study, please click here to get in touch. Related links British Heart Foundation Professor Joanna Wardlaw LACunar Intervention Trial-2 (LACI-2) Brain & nervous system Small vessel disease (SVD) Stroke Dementia The Scotsman article British Heart Foundation article 21 Apr 20. Featured Paper. Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease. 24 Apr 19. New Stroke Drug 23 May 18. New trial for stroke - LACI-2 Social media tags & titles An article highlighting the second-largest study ever into lacunar strokes, LACI-2, led by Professor Joanna Wardlaw, was featured in the Scotsman. @BHFScotland @TheBHF @EdinUniBrainSci @fergusdoubal @SVDs_at_target @UKDRI @IST_3 @edinburghstroke @WorldStrokeOrg @ESOstroke #SmallVesselDisease #LacunarStroke #LACI2 Publication date 07 Dec, 2020
